Forkhead box (FOX) transcription factors compose a large family of regulators of key biological processes within a cell. FOXK2 is a member of FOX family, whose biological functions remain relatively unexplored, despite its description in the early nineties. More recently, growing evidence has been pointing towards a role of FOXK2 in cancer, which is likely to be context-dependent and tumour-specific. Here, we provide an overview of important aspects concerning the mechanisms of regulation of FOXK2 expression and function, as well as its complex interactions at the chromatin level, which orchestrate how it differentially regulates the expression of gene targets in pathophysiology. Particularly, we explore the emerging functions of FOXK2 as a regulator of a broad range of cancer features, such as cell proliferation and survival, DNA damage, metabolism, migration, invasion and metastasis. Finally, we discuss the prognostic value of assessing FOXK2 expression in cancer patients and how it can be potentially targeted for future anticancer interventions.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468357 | PMC |
| http://dx.doi.org/10.3390/cancers11030393 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Foxk2 Enhances Adipogenic Differentiation by Relying on the Transcriptional Activation of Peroxisome Proliferator-Activated Receptor Gamma.
J Cell Mol Med
January 2025
NHC Key Lab of Hormones and Development and Tianjin Key Lab of Metabolic Diseases, Tianjin Medical University Chu Hsien-I Memorial Hospital & Institute of Endocrinology, Tianjin, China.
Proper differentiation of bone marrow stromal cells (BMSCs) into adipocytes is crucial for maintaining skeletal homeostasis. However, the underlying regulatory mechanisms remain incompletely understood, posing a challenge for the treatment of age-related osteopenia and osteoporosis. Here, through comprehensive gene expression analysis during BMSC differentiation into adipocytes, we identified the forkhead transcription factor Foxk2 as a key regulator of this process.
View Article and Find Full Text PDFThe role of FOXK2-FBXO32 in breast cancer tumorigenesis: Insights into ribosome-associated pathways.
Thorac Cancer
November 2024
Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China.
Objective: To search for a new biomarker that can predict the efficacy and prognosis of tumor immunotherapy.
Method: FOXK2 genes were analyzed using single-cell sequencing in pan-cancer bulk RNA-seq from the TCGA database. We used algorithms to predict their immune infiltration.
FoxK1 and FoxK2 cooperate with ORF45 to promote late lytic replication of Kaposi's sarcoma-associated herpesvirus.
J Virol
December 2024
Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, China.
Article Synopsis
- KSHV (Kaposi's sarcoma-associated herpesvirus) relies on lytic replication for persistent infection, with its proteins hijacking cellular pathways for this process.
- The study identifies that the proteins FoxK1 and FoxK2 bind with the KSHV protein ORF45, playing a crucial role in late viral gene expression and virion production.
- The interaction between ORF45 and FoxK1/FoxK2 enhances transcriptional activity at late viral promoters, facilitating KSHV lytic replication and revealing their new roles in KSHV pathogenesis.
FOXK2 facilitates the airway remodeling during chronic asthma by promoting glycolysis in a SIRT2-dependent manner.
FASEB J
July 2024
Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, China.
Article Synopsis
- - Asthma, a worldwide chronic lung disease, involves structural changes in the airway walls known as "airway remodeling," which significantly contributes to airway dysfunction.
- - In a study with mice subjected to asthma induction, it was found that the transcription factor FOXK2 was elevated in their lungs; knocking it down led to reduced inflammation and glycolysis, suggesting FOXK2 plays a role in airway remodeling.
- - Furthermore, FOXK2 was shown to regulate the process of epithelial-mesenchymal transition (EMT) and glycolysis in human bronchial cells through its interaction with SIRT2, indicating that targeting FOXK2 could be a potential strategy for alleviating asthma symptoms.
FOXK2 amplification promotes breast cancer development and chemoresistance.
Cancer Lett
August 2024
Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. Electronic address:
Article Synopsis
- FOXK2 is a gene that can become too active or copied too much, which plays a big role in helping cancer, especially in breast cancer.
- Research shows that when FOXK2 is more present, it can lead to worse outcomes for patients, but reducing FOXK2 helps slow down cancer growth.
- Scientists found that targeting FOXK2 with certain drugs could work better together with other cancer treatments, showing that FOXK2 might be a good target for new breast cancer therapies.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!